Skip to content
healthcare.dev

Irinotecan hydrochloide

NDC 68083-381, Irinotecan hydrochloide, injection, from Gland Pharma Limited.

Product NDC
68083-381
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212993
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
68083-381-01680830381011 VIAL, SINGLE-DOSE in 1 CARTON (68083-381-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/de634e80-328a-4473-b395-0172683a2411

Use it

Look up 68083-381 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.